Last Price | 7.35 | Max Price | 7.80 |
Min Price | 4.55 | 1 Year return | 58.75 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 413 | 2,019,579 | 0.02 % |
2020 | 420 | 2,170,517 | 0.02 % |
2021 | 45 | 2,404,876 | 0.00 % |
2022 | 126 | 2,645,792 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Greatbatch's core business is the health care eq. & services sector. Between 2006 and 2016 the global health care companies gained around 102 percent. Over the past 5 years the sector is 64 percent higher.
The American company didn't pay out any dividends (in the past 5 years).
As per the end of 2015 the American company's balance sheet equaled 2,98 billion dollars. At the end of 2015 the total debt positon equaled 2,13 billion dollars. This is around 71,48 percent of the total balance sheet. As per the end of 2015 Greatbatch's price/earnings-ratio equaled 33. So investors paid for 1 stock 33 times the earnings per share of 2015. Based on the classical stock valuation theories the American stock can be seen as a growth stock.
The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 1,37 billion dollars. At the end of 2015 the American company had around 26,36 million stocks listed on the stock exchange(s).
All Greatbatch's annual reports can be found here. More information about Greatbatch can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
413
|
420
|
Costs |
0
|
0
|
0
|
0
|
411
|
424
|
Profit |
0
|
0
|
0
|
0
|
2
|
-4
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.57
|
-0.84
|
ROI |
0.0
|
0.0
|
0.0
|
0.0
|
2.99
|
-5.59
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
0
|
0
|
79
|
63
|
Debt |
0
|
0
|
0
|
0
|
1,121
|
1,061
|
Total assets |
0
|
0
|
0
|
0
|
1,199
|
1,124
|
Solvency |
0.0
|
0.0
|
0.0
|
0.0
|
6.55
|
5.61
|
Cash |
0
|
0
|
0
|
0
|
104
|
226
|
Cashflow |
0
|
0
|
0
|
0
|
114
|
189
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
0.0
|
0.0
|
0.10
|
0.18
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
9.65
|
7.35
|
Eps |
0.0
|
0.0
|
0.0
|
0.06
|
-0.09
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
160.83
|
-81.67
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
0.0
|
0.0
|
1.96
|
1.58
|
Market to book |
0.0
|
0.0
|
0.0
|
0.20
|
0.21
|
Cashflow per stock |
0.0
|
0.0
|
0.0
|
2.86
|
4.73
|
Stocks |
0
|
0
|
0
|
40
|
40
|
Market Cap |
0.00
|
0.00
|
0.00
|
386.00
|
294.00
|
Date
|
Price
|
---|---|
20 Mar 2025
|
7.35
|
15 Mar 2025
|
7.33
|
12 Mar 2025
|
7.32
|
01 Mar 2025
|
7.31
|
25 Feb 2025
|
7.32
|
23 Feb 2025
|
7.31
|
18 Feb 2025
|
6.54
|
13 Feb 2025
|
6.63
|
12 Feb 2025
|
6.53
|
07 Feb 2025
|
6.47
|
05 Feb 2025
|
6.75
|
02 Feb 2025
|
6.94
|
21 Jan 2025
|
7.39
|
17 Jan 2025
|
7.65
|
09 Jan 2025
|
7.80
|
17 Dec 2024
|
6.08
|
10 Dec 2024
|
6.02
|
06 Dec 2024
|
5.92
|
03 Dec 2024
|
5.50
|
29 Nov 2024
|
6.08
|
27 Nov 2024
|
5.71
|
13 Nov 2024
|
5.51
|
08 Nov 2024
|
5.30
|
05 Nov 2024
|
5.53
|
31 Oct 2024
|
5.59
|
29 Oct 2024
|
5.63
|
23 Oct 2024
|
5.18
|
19 Oct 2024
|
5.23
|
16 Oct 2024
|
5.33
|
14 Oct 2024
|
5.27
|